Please login to the form below

Not currently logged in
Email:
Password:

haematology

This page shows the latest haematology news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug

Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug

The Danish drugmaker is paying $400m overall for rights to the EPI01 programme in haematology, which includes an upfront fee and development and sales milestone payments, as well as royalties on

Latest news

More from news
Approximately 20 fully matching, plus 118 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    Merck’s success in oncology will likely continue, driven by Keytruda’s lead in the frontline non-small cell lung cancer setting, ”says Cai Xuan, senior analyst, oncology and haematology, GlobalData.

  • Biologic or biosimilar: what are prescribers thinking? Biologic or biosimilar: what are prescribers thinking?

    To answer these questions, SKIM surveyed physician key opinion leaders (KOLs) working in oncology and haematology across leading EU markets.

  • Pharma deals continue to slide Pharma deals continue to slide

    250+. Immunogen (US). Jazz (IE, US). Collaboration and option. Phase I haematology-related antibody-drug conjugate plus 2 other projects.

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    Despite these advantages, the low number of medically qualified candidates choosing to enter haematology, and more specifically haemostasis, remains a big challenge. ... The problem is particularly acute in the USA, where the majority of newly qualified

  • A rare talent A rare talent

    It allowed us to solidify our position as the world's largest rare disease company and we now are the leaders in haematology, lysosomal storage disorders with strong capabilities in ADHD

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics